Target intelligence / Profile preview

Crotalinae snake venom toxin

Molecular classification
Other
01

Overview

Crotalinae snake venom toxins are a complex mixture of proteins and enzymes produced by snakes in the subfamily Crotalinae (pit vipers), such as rattlesnakes, cottonmouths, and copperheads. These mixtures are not a single molecular target, but rather contain diverse protein classes including neurotoxins, myotoxins, cytotoxins, hemotoxins, and enzymes like metalloproteinases and phospholipase A2, each acting via different pathological mechanisms including membrane disruption, tissue necrosis, coagulopathy, and modulation of ion channels. Rather than being a therapeutic drug target, these venoms are the cause of envenomation, and antivenoms (such as CroFab) are used to bind and neutralize the toxins, reducing morbidity and mortality. The entry "Venom toxins from Crotalinae snakes" does not refer to a specific drug target, but instead to a heterogenous mixture of toxins, so it should not be considered a defined molecular target for structured pharmaceutical targeting[1][2][3][5][6].

Other names
Crotalid venomPit viper venomRattlesnake venomCrotalinae pit viper toxins
02

Mechanism of action

Neutralization and clearance of venom toxins by antigen-binding fragments (Fab) of antibodies

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

High complexity and variabilitymixture of toxin typeschallenges in standard drug targetingrisk of severe tissue damage, coagulopathy, systemic toxicity
06

Interacting drugs

CroFab (crotalidae polyvalent immune Fab)

Beyond the preview

Go deeper on Crotalinae snake venom toxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crotalinae snake venom toxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call